Titanium Zirconium (TiZr) Mini Implants

February 16, 2026 updated by: University of Bern

Is the Stabilization of a Mandibular Overdenture Employing Four Novel One-piece Immediately Loaded TiZr Implants With Miniaturized Stud-type Attachments a Feasible Alternative to Two Two-piece Early Loaded Tissue-level Implants With Regular Stud-type Attachments?

H0: "Within the first year post-placement, four interforaminally placed, immediately loaded 2.4 mm narrow-diameter one-piece TiZr implants with miniaturized stud-type attachments show improved patient-reported outcome measures (PROMS) compared to two interforaminally placed, early loaded, TiZr two-piece implants with stud-type attachments to retain a mandibular overdenture."The specific aim is to compare both treatment alternatives to evaluate which one may be recommended for elderly edentulous patients.

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bern, Switzerland, 3010
        • University of Bern
    • Canton of Bern
      • Langenthal, Canton of Bern, Switzerland, 4900
        • Private Practice Dr. B. Wallkamm

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • At patient level:

    • Written informed consent
    • Age ≥ 18 years
    • Sufficient complete dentures (Marxkors and Ferger, 1989) not older than 1 year
    • Patient is unsatisfied with mandibular denture to the degree that he/she seeks treatment
  • At site level:

    • Healed edentulous mandible (minimum 8 weeks since last extraction)
    • Minimal ridge dimensions 5.5 mm (width) by 12 mm (height) in the anterior (interforaminal) area, allowing the placement of 3.3 (endosseous diameter) by 10 mm (length) implants
    • Opposing dentition: complete denture on a edentulous maxilla
    • Physical status (PS) 1 and 2 (American Society of Anesthesiologists)

Exclusion Criteria:

  • At patient level

    • Any physical or mental disorder that would interfere with the ability to perform adequate oral hygiene or the capability of providing written informed consent and compliance to the protocol
    • Any disorder that would interfere with wound healing or represent a contraindication for oral surgery such as, but not limited to, uncontrolled diabetes or conditions resulting in or requiring immunosuppression, radiation, chemotherapy, frequent use of antibiotics or antiresorptive medication such as bisphosphonates
    • Pregnancy or lactation
    • Heavy smoking habit with > 20 cig/d
    • Severe bruxism or clenching habits, present oro-facial pain
  • At site level:

    • Ridge defects requiring staged bone augmentation procedures (simultaneous Guided Bone Regeneration (GBR) within the ridge contour allowed)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Control-group
Two Tissue Level TiZr Sand blasted long grit acid-etched (SLA) implants placed in positions 33 and 43 (diameter 3.3mm, length ≥10mm), early loading
two TiZr implants on SLA surface
Experimental: Experimental-group
Four narrow-diameter implants (NDI) TiZr SLA implants in positions 34, 32, 42, and 44 (diameter 2.4mm, length ≥10mm), immediate loading
four TiZr implants on SLA surface

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Geriatric Oral Health Assessment Index (GOHAI)
Time Frame: One-year follow-up

Change from baseline questionnaires in Oral Health Related Quality of Life (OHRQoL).

Scores 0-60: higher values represent lower OHRQoL

One-year follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Additional Oral Health Impact Profile for edentulism (OHIP-EDENT)
Time Frame: Follow-up (up to 365 days)
Change from baseline questionnaires
Follow-up (up to 365 days)
Additional PROM Denture Satisfaction Index (DSI)
Time Frame: Baseline, follow-up (up to 365 days)
Change in Denture Satisfaction higher values represent better satisfaction (0-1200mm)
Baseline, follow-up (up to 365 days)
Implant Survival
Time Frame: at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up
Survival (yes/no)
at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up
Implant Success
Time Frame: at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up
Success according to Misch (2007) Misch criteria scores 1-4: higher values represent better success
at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up
Prosthetic Survival
Time Frame: Baseline, follow-up (up to 365 days)
Prosthetic Survival (yes/no): is the denture still in place?
Baseline, follow-up (up to 365 days)
Chewing Efficiency
Time Frame: Baseline, follow-up (up to 365 days)
Color mixing test
Baseline, follow-up (up to 365 days)
Plaque Index
Time Frame: at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up

Plaque Index Scores 0-3 3= thick plaque is visible along gingival margin 2= plaque is visible along gingival margin, with or without air drying

1= following air drying, plaque is not visible but can be wiped off with an explorer 0= following air drying, plaque is not visible nor can be wiped off with an explorer

at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up
Bleeding Index
Time Frame: at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up

Bleeding Index Scores 0-3 0= Healthy gingival

  1. Gingival look inflamed, but don't bleed when probed
  2. Gingival look inflamed and bleed when probed
  3. Ulceration and spontaneous bleeding
at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up
Pocket Probing depth
Time Frame: at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up
depth measured in mm
at implant loading (at 24 hours for arm B, at 6-8 weeks for arm A), at the one-year follow-up
Time-Cost-Analysis
Time Frame: After surgery, after implants loading, after follow-up (up to 365 days)
Total treatment time will be collected and added. Total treatment cost will be evaluated and a ratio will be calculated. The groups will be compared on the base of this ration
After surgery, after implants loading, after follow-up (up to 365 days)
Cost Effectiveness and Willingness to Pay
Time Frame: Total change and time at 1y follow-up
Cost effectiveness wil be calculated as a ratio of treatment cost in relation to change of GOHAI sum score. This will allow to evaluate how much monetary item is needed to achieve a change in GOHAI
Total change and time at 1y follow-up
In-vivo evaluated loss of retentive force
Time Frame: after implant loading (expected to be after 6 weeks on average) and at follow-up (up to 365 days)
Measurement with a hand-held digital force gauge
after implant loading (expected to be after 6 weeks on average) and at follow-up (up to 365 days)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Beat Wallkamm, Dr, Private Practice
  • Study Director: Martin Schimmel, Prof, University of Bern

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2019

Primary Completion (Actual)

September 10, 2024

Study Completion (Estimated)

August 1, 2033

Study Registration Dates

First Submitted

January 30, 2019

First Submitted That Met QC Criteria

February 6, 2019

First Posted (Actual)

February 12, 2019

Study Record Updates

Last Update Posted (Actual)

February 18, 2026

Last Update Submitted That Met QC Criteria

February 16, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

It is not planned to use the data of this study for future research.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Implants

Clinical Trials on early loading

Subscribe